Evidence map›Paper›PMID 41973869›Full record

ArticleJMIR research protocols2026

Feasibility of Internet-Based Mind-Body Training for Adults With Subjective Cognitive Decline: Protocol for a Randomized Controlled Trial.

Ruchika S Prakash, Madhura Phansikar, Megan E Fisher, Sarah Dove, Rebecca Andridge, Doug Scharre, Kathy D Wright, Elizabeth Head, Claire O'Callaghan, Quinn K Meyerson and 10 more

Abstract readClinical Trial Protocol
In one paragraph

Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ruchika S PrakashDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0002-2224-6242
Madhura PhansikarDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0001-5738-1447
Megan E FisherDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0002-3380-1248
Sarah DoveOffice of Curriculum and Scholarship, College of Medicine, The Ohio State University, Columbus, OH, United States.ORCID 0009-0000-5326-4841
Rebecca AndridgeDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, United States.ORCID 0000-0001-9991-9647
Doug ScharreDepartment of Neurology, College of Medicine, The Ohio State University, Columbus, OH, United States.ORCID 0000-0001-8622-3923
Kathy D WrightCollege of Nursing, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.ORCID 0000-0001-7346-1981
Elizabeth HeadDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.ORCID 0000-0003-1115-6396
Claire O'CallaghanSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID 0000-0001-5698-6364
Quinn K MeyersonDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0009-0006-7164-3128
Elizabeth J DuraneyDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0003-1954-4342
Matthew SchroederDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0002-5616-1423
Niyathi ChakrapaniDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0009-0001-0107-1535
Elise K GrantDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0009-0008-0100-8289
Tyreek JonesDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0009-0009-7325-4750
James TengDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0002-4154-6339
Michael EstermanNational Center for PTSD, VA Boston Healthcare System, Boston, MA, United States.ORCID 0000-0002-9000-3920
Joshua M SmythDepartment of Psychology, College of Arts & Sciences, The Ohio State University, 1835 Neil Avenue, Columbus, OH, 43210, United States, 1 6142928462.ORCID 0000-0002-0904-5390
Thomas GregoireCollege of Social Work, The Ohio State University, Columbus, OH, United States.ORCID 0000-0003-2136-0454
Rond MalhasDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.ORCID 0009-0003-6227-2079

Funding

Development of an online mindfulness training program for adults with subjective cognitive declineR61AG081982 · NIA · OHIO STATE UNIVERSITY · PI PRAKASH, RUCHIKA SHAURYA · 2024 to 2025
$1.0M
NIA NIH HHS R61 AG081982
6 · The paper itself

Abstract

Background: In the United States, the prevalence of Alzheimer disease (AD) is projected to double over the next 30 years, with associated familial and societal costs estimated at US $1 trillion annually if current trends continue. Although pharmacological treatments of AD are showing promise, the adoption of healthy lifestyle behaviors, particularly during the preclinical phase of AD, may reduce dementia rates by up to 45%. Subjective cognitive decline (SCD), defined as persistent self-perceived declines in cognitive functioning compared with previously normal cognitive abilities, has been identified as a potential preclinical stage of AD. Objective: This randomized controlled trial aims to evaluate the feasibility and acceptability of an internet-based, asynchronous mindfulness-based stress reduction program compared with an active control group (an internet-based lifestyle education program). Secondary objectives include examining preliminary effects of each intervention on SCD, plasma-based biomarkers of amyloid and tau pathology, and everyday mind-wandering. Methods: Sixty adults aged 50 years and older will be screened for SCD in the absence of objective cognitive impairment, based on the Uniform Data Set Neuropsychological Battery (version 3.0) from the National Alzheimer's Coordinating Center. Eligible and consenting participants will complete behavioral and imaging-based tasks of sustained attention and mind-wandering, as well as blood draws at baseline and after the 8-week intervention. After baseline assessments, participants will be randomized to either an internet-based, asynchronous mindfulness-based stress reduction program or the internet-based lifestyle education program. Both programs have been adapted from our manualized in-person programs and refined through focus group interviews with the target population. Results: The study was funded in April 2024. Phase 1 focused on iterative development of the 2 programs based on focus group feedback. Recruitment for the randomized controlled trial (internet-based mind-body training trial) began in June 2025 and is ongoing. Recruitment is expected to conclude in September 2026, with data collection ending in December 2026. Conclusions: Behavioral, lifestyle-based interventions that emphasize experiential practices show promise as preventative strategies to prevent decline in cognitive and brain health. Yet, there remain significant barriers to engaging with in-person programs, including limited accessibility, time and schedule constraints, and travel logistics. The internet-based mind-body training trial will evaluate the feasibility and acceptability of 2 fully online, mind-body training programs for adults at risk for AD. Future Stage II and Stage III studies will be necessary to establish the efficacy of these programs for improving AD biomarkers and cognitive outcomes and their broader dissemination to adults noticing subtle changes in cognitive functioning.

Indexed as

Cognitive DysfunctionInternet-Based InterventionMind-Body TherapiesAgedBiomarkersFeasibility StudiesFemaleHumansInternetMaleMiddle AgedMindfulnessRandomized Controlled Trials as TopicBiomarkersamyloid and tau pathologymindfulnessonline mind-body interventionspilot randomized controlled trialsubjective cognitive decline

Identifiers

PMID41973869
PMCPMC13075639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.